Chinese Heparin API Manufacturer Not Inspected By SFDA
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's State FDA has never inspected an API manufacturer that may be linked to a safety scare over Baxter Healthcare's injectable heparin, officials confirmed to PharmAsia News